| Mrs Kelly Renae Sukola, MA, IMFT | |
|
267 S. Marine Corps Drive, Suite 2d, Tamuning, GU 96913 | |
| (671) 646-7972 | |
| (671) 647-7972 |
| Full Name | Mrs Kelly Renae Sukola |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 267 S. Marine Corps Drive, Tamuning, Guam |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427372812 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | IMF74 (Guam) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kelly Renae Sukola, MA, IMFT 267 S. Marine Corps Drive, Suite 2d, Tamuning, GU 96913 Ph: (671) 646-7972 | Mrs Kelly Renae Sukola, MA, IMFT 267 S. Marine Corps Drive, Suite 2d, Tamuning, GU 96913 Ph: (671) 646-7972 |
News Archive
Researchers at Fred Hutchinson Cancer Research Center have developed biodegradable nanoparticles that can be used to genetically program immune cells to recognize and destroy cancer cells - while the immune cells are still inside the body.
Cantex Pharmaceuticals, a clinical stage biopharmaceutical company developing medications that block critical mechanisms by which cancer spreads and resists treatment, today announced Tibor Kovacsovics, M.D., Medical Director for the Inpatient Service of the Division of Hematology and Hematologic Malignancies and Director of Hematologic Malignancy Clinical Research at Huntsman Cancer Institute presented a poster related to Cantex's lead compound, CX-01, at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO).
In an effort to rally public support for the overhaul, President Barack Obama will talk about provisions that benefit women as part of a Mother's Day-themed event.
The European Investment Bank (EIB) is supporting the development of new wireless hearing devices and research into more effective acoustic implants by global leader William Demant Holding A/S through a EUR 110 million loan.
The work of researchers Francesc Viñals and Mariona Graupera at the Bellvitge Biomedical Research Institute - Catalan Institute of Oncology - University of Barcelona, together with Dr. Antoni Riera-Mestre, has led to a new potential treatment for Hereditary Hemorrhagic Telangiectasia or Rendu-Osler Syndrome, a rare disease that affects blood vessels and had no described treatment.
› Verified 7 days ago
Mrs. Sylvia T Quinata, MA, IMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 790 Governor Carlos Camacho Rd., Tamuning, GU 96913 Phone: 671-647-5325 Fax: 671-647-0250 |